ALCAINE

This brand name is authorized in Canada, Cyprus, Ecuador, Estonia, Hong Kong, Lithuania, New Zealand, Poland, Singapore, Turkey, United States

Active ingredients

The drug ALCAINE contains one active pharmaceutical ingredient (API):

1 Proparacaine UNII U96OL57GOY - PROPARACAINE HYDROCHLORIDE

Proxymetacaine is a potent topical anaesthetic of the ester type. The main site of anaesthetic action is the nerve cell membrane where proxymetacaine interferes with the large transient increase in the membrane permeability to sodium ions that is normally produced by a slight depolarisation of the membrane. Read about Proparacaine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ALCAINE Eye drops, solution	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01HA04	Proxymetacaine	S Sensory organs → S01 Ophthalmologicals → S01H Local anesthetics → S01HA Local anesthetics
Discover more medicines within S01HA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00035076
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.838-08-04
Country: EE	Ravimiamet	Identifier(s): 1123849
Country: HK	Department of Health Drug Office	Identifier(s): 21472
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010023
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14831
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100003640
Country: SG	Health Sciences Authority	Identifier(s): 04718P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699760611360
Country: US	FDA, National Drug Code	Identifier(s): 0998-0016